My dad, a retired Bell Labs physicist, has been quietly resigned for many years to the fact that neither of his kids are smart enough to understand and appreciate math & physics the way he does. But now it's becoming clear my 11yo is terrifyingly smart, she engages with him on mathematical puzzles in a way I've simply never been capable of, and hope is returning to his eyes. It's both wonderful and heartbreaking for me to witness
@pstavirs Well, reading the article it was for 25,000 crore of fixed deposits; so I think all top management was incentivized by their organizational bonus targets is my benign reading. Even the retail branch manager nags us for 50K FD before they will "allow us" to rent a locker, so.
Onboard views from Starship and Super Heavy V3, which are equipped with upgraded cameras capable of streaming 4K video through every phase of flight via @Starlink
Operators and ISPs publishing their self-attested IP geolocation feeds is a welcome direction, and Regional Internet Registries really need to make it much easier. @lacnic is the early-adopter; relieved to see @TeamARIN is stepping up now. @apnic - the ball's in your court :)
IP geolocation was never part of the original design, but your network depends on it.
At #NANOG97, ARIN CTO Mark Kosters joins a panel on advancing #geolocation via Geofeeds & RIR standards. Plan to tune in at 10-11 AM PT on 2 June.
https://t.co/0UZ0DdhHfl
#WeAreNANOG@nanog
@DaryllSwer@lacnic@TeamARIN@apnic ARIN is warming up to it. Good to know APNIC has stable support.
All are trying to move to RDAP more aggressively, and I am sure what’s their adoption plan for standardized/normalized tags such as rfc 9877
https://t.co/LW4WvoX6oV
@wesbos I've been surprised MCP apps haven't taken off. It feels like this should be the next major app platform... and yet, really nothing meaningful yet? Why hasn't ChatGPT beocome a superapp?
Eli Lilly released retatrutide Phase 3 data yesterday. 28% weight loss in 80 weeks. The most powerful obesity drug that’s ever been tested.
And today the cancer signal drops.
12,112 patients. Seven tumor types. GLP-1 users had half the lung cancer metastasis rate (10% vs 22%). Breast cancer: 43% cut. Colon cancer five-year mortality in a separate study: 15.5% vs 37.1%.
Cancer joins a list that already includes heart disease (SELECT, 20% MACE reduction), kidney failure (FLOW, 24% slower decline), sleep apnea (SURMOUNT-OSA, FDA-approved), addiction (BMJ, 600K veterans, 18-25% reduction across substances), and liver disease (86% fat clearance).
Tumors express GLP-1 receptors. Activate them and NF-kB drops, apoptosis rises. The drug isn’t just shrinking fat. It’s talking directly to the cancer.
One drug class. Designed for blood sugar. The biology keeps finding uses the designers didn’t predict.
Now if only GoI + states could smoothen refunds of GST input tax credit for genuine exporters ! There is still too much burden of proof required to get a rupee back
You look away from India FX for half a day and there’s a pile up of action to catch up on:
Another low. 97/$ in sight: https://t.co/2xNtnGfVut
RBI has been selling dollars at a pace of a billion dollars a day just to slow the decline: https://t.co/nfJm6UDXtV
And naturally that hits liquidity, so RBI announces an FX swap to balance that out: https://t.co/Yu9OX086kk